Portal Innovations to call Houston its third home, with CAR-T startup March Biosciences already in the portfolio

Kyle LaHucik

Senior Reporter

Portal Innovations, a biotech investor and lab operator, is spreading its blueprint to Houston as it looks to seed new Texas startups with $25 million …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Portal Innovations to call Houston its third home, with CAR-T startup March Biosciences already in the portfolio

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

Deputy FDA chief mulls shaking up PDUFA reauthorization structure

Lower attendance at cell and gene therapy conference mirrors challenged industry

Updated: Novo Nordisk CEO to step down amid stock decline, timeline for successor unknown

FDA poses efficacy, safety questions over four cancer drugs ahead of two-day adcomm

Novo Nordisk’s global obesity leader is moving on; Flagship biotech gets CEO from Scholar Rock

'Go ahead and do it': Top RFK Jr. deputy dares drugmakers that might pull manufacturing over new price pressure

Por­tal In­no­va­tions to call Hous­ton its third home, with CAR-T start­up March Bio­sciences al­ready in the port­fo­lio

Senior Reporter

Sign up to read this article for free.

more like this

ImmunityBio, Inc.

Remote

Portal Innovations to call Houston its third home, with CAR-T startup March Biosciences already in the portfolio